Tali-Anne Szwebel to Humans
This is a "connection" page, showing publications Tali-Anne Szwebel has written about Humans.
Connection Strength
0.032
-
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient. Stem Cell Rev Rep. 2021 02; 17(1):296-299.
Score: 0.007
-
Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality. Arthritis Rheumatol. 2021 11; 73(11):1976-1985.
Score: 0.002
-
Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19. Int J Mol Sci. 2021 Jul 12; 22(14).
Score: 0.002
-
White blood count, D-dimers, and ferritin levels as predictive factors of pulmonary embolism suspected upon admission in noncritically ill COVID-19 patients: The French multicenter CLOTVID retrospective study. Eur J Haematol. 2021 Aug; 107(2):190-201.
Score: 0.002
-
Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost. 2021 07; 19(7):1823-1830.
Score: 0.002
-
D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients. Viruses. 2021 04 26; 13(5).
Score: 0.002
-
Interferon-ß Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2. J Clin Immunol. 2021 07; 41(5):931-933.
Score: 0.002
-
Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis. 2021 08; 24(3):505-517.
Score: 0.002
-
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19. Blood. 2020 11 12; 136(20):2290-2295.
Score: 0.002
-
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19. Cell. 2020 09 17; 182(6):1401-1418.e18.
Score: 0.002
-
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020 08 07; 369(6504):718-724.
Score: 0.002
-
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. BMJ. 2020 May 14; 369:m1844.
Score: 0.002
-
Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer. Neurology. 2018 09 04; 91(10):e985-e994.
Score: 0.002
-
Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis. Eur J Cancer. 2017 09; 82:34-44.
Score: 0.001
-
Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy. Ann Rheum Dis. 2018 03; 77(3):468-470.
Score: 0.001